Prostate cancer cells elevate glycolysis and G6PD in response to caffeic acid phenethyl ester-induced growth inhibition.

Saved in:
Bibliographic Details
Title: Prostate cancer cells elevate glycolysis and G6PD in response to caffeic acid phenethyl ester-induced growth inhibition.
Authors: Lin TP; Faculty of Medicine, National Yang Ming Chiao Tung University, Hsinchu City, 30010, Taiwan.; Department of Urology, Taipei Veterans General Hospital, Taipei City, 11217, Taiwan., Chen PC; Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli County, 35053, Taiwan., Lin CY; Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli County, 35053, Taiwan.; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University, Taipei City, 11031, Taiwan., Wang BJ; Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli County, 35053, Taiwan., Kuo YY; Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli County, 35053, Taiwan., Yeh CC; Department of Education and Medical Research, Taoyuan Armed Forces General Hospital, Taoyuan City, 325208, Taiwan.; Division of Colon and Rectal Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei City, 114202, Taiwan., Tseng JC; Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli County, 35053, Taiwan.; Immunology Research Center, National Health Research Institutes, Miaoli County, 35053, Taiwan., Huo C; Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli County, 35053, Taiwan., Kao CL; Division of Urology, Departments of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei City, 114202, Taiwan.; Division of Urology, Department of Surgery, Taoyuan Armed Forces General Hospital, Taoyuan City, 325208, Taiwan., Shih LJ; Division of Colon and Rectal Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei City, 114202, Taiwan.; Graduate Institute of Medical Science, National Defense Medical Center, Taipei City, 114202, Taiwan., Chen JK; Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli County, 35053, Taiwan., Li CY; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung City, 80708, Taiwan.; Department of Medical Research, Kaohsiung Medical University, Kaohsiung City, 80708, Taiwan., Hour TC; Neuroscience Research Center, Kaohsiung Medical University, Kaohsiung City, 80708, Taiwan.; Department of Biochemistry, School of Medicine, Kaohsiung Medical University, Kaohsiung City, 80708, Taiwan.; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung City, 80708, Taiwan., Chuu CP; Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli County, 35053, Taiwan. cpchuu@nhri.edu.tw.; PhD Program for Aging, China Medical University, Taichung City, 40402, Taiwan. cpchuu@nhri.edu.tw.; Biotechnology Center, National Chung Hsing University, Taichung City, 40227, Taiwan. cpchuu@nhri.edu.tw.; Department of Life Sciences, National Central University, Taoyuan City, 32031, Taiwan. cpchuu@nhri.edu.tw.
Source: BMC cancer [BMC Cancer] 2025 Jan 16; Vol. 25 (1), pp. 95. Date of Electronic Publication: 2025 Jan 16.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1471-2407
DOI:10.1186/s12885-025-13477-6